LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
LivaNova PLC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$78.14+0.56 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $4.40B
- P/E (TTM)
- 23.1
- Dividend yield
- –
Share price
+$24.41 (+45.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
LivaNova PLC grew revenue 12.4% to $1.47B over the twelve months to Jun 30, 2026. Operating income rose 6.9% to $187.55M, moving the operating margin from 13.4% to 12.7%. Free cash flow was $148.31M, down 8.5% from a year earlier.
Revenue
$1.47B
+12.4% vs. a year earlier
Operating income
$187.55M
+6.9% vs. a year earlier
Free cash flow
$148.31M
-8.5% vs. a year earlier
EPS, diluted
$3.39
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.40B
- P/E ratio
- 23.1
- Price to sales
- 2.99
- Price to book
- 3.32
- Dividend yield
- –
- Free cash flow yield
- 3.37%
Fundamentals
- Revenue
- $1.47B
- Net income
- $188.55M
- EPS, diluted
- $3.39
- Free cash flow
- $148.31M
- Book value per share
- $23.55
- Diluted shares
- 56M
Thirteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
$1.47B+12.4% YoY
Gross profit
$1.00B+12.5% YoY
Operating income
$187.55M+6.9% YoY
Net income
$188.55M
EPS, diluted
$3.39
Free cash flow
$148.31M-8.5% YoY
Reported periodTrailing twelve months